Advances in the Development of Macrocyclic Inhibitors of Hepatitis C Virus NS3-4A Protease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|10|14|1403-1422

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.10, Iss.14, 2010-10, pp. : 1403-1422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry

By  

Current Medicinal Chemistry, Vol. 23, Iss. 29, 2016-10 ,pp. : 3404-3447

Bentham Science Publishers

Access to resources Recommend Favorite

In Silico Screening for Potent Inhibitors against the NS3/4A Protease of Hepatitis C Virus

By  

Current Pharmaceutical Design, Vol. 20, Iss. 21, 2014-05 ,pp. : 3465-3477

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Hepatitis C Virus NS3.4A Protease: P2 Proline Variants

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-01 ,pp. : 497-502

Bentham Science Publishers

Access to resources Recommend Favorite

Computer-Assisted Analysis of the Interactions of Macrocyclic Inhibitors with wild Type and Mutant D168A Hepatitis C Virus NS3 Serine Protease

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 1, 2006-02 ,pp. : 17-28

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 3-16

Bentham Science Publishers

Access to resources Recommend Favorite